About Biotecnofe
Biotecnofe was founded in 2018 by Enrique Ariotti in Santa Fe, Argentina. Operations focus on the veterinary biotherapeutics sector, where research and development services are provided to support biopharmaceutical advancements for animal health. The company conducts studies and trials tailored to veterinary applications, serving clients in the region through its specialized expertise in biological therapies.
- Headquarter Santa Fe, Argentina
- Founders Enrique Ariotti
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biotecnofe
Detailed funding history for Biotecnofe
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Biotecnofe
Biotecnofe has secured backing from 1 investor. Prominent investors backing the company include Ceva.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Animal health therapeutics are developed and supplied globally by Ceva.
|
Locked | Locked | Locked |
Investor details for Biotecnofe
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biotecnofe
Investment portfolio details for Biotecnofe
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biotecnofe
Detailed financials for Biotecnofe
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biotecnofe Comparisons
Peer comparison for Biotecnofe
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biotecnofe
Detailed competitors of Biotecnofe
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biotecnofe
Complete news archive for Biotecnofe
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biotecnofe
Biotecnofe was founded in 2018.
Biotecnofe is headquartered in Santa Fe, Argentina. It is registered at Santa Fe, Santa Fe, Argentina.
Biotecnofe was founded in 2018 by Enrique Ariotti in Santa Fe, Argentina. Operations focus on the veterinary biotherapeutics sector, where research and development services are provided to support biopharmaceutical advancements for animal health. The company conducts studies and trials tailored to veterinary applications, serving clients in the region through its specialized expertise in biological therapies.
Biotecnofe has 1 investor. Key investors include Ceva.